Lithium chloride (LiCl) is widely prescribed for the treatment of bipolar disorders and is associated with a higher incidence of reproductive adverse effects. Cyclooxygenase (COX)-2 and its derivative, prostaglandin E2 (PGE2), play regulatory roles in the human ovulatory process. Whether LiCl affects ovulation by regulating COX2 expression and PGE2 production in the human ovary is still largely unknown. The aim of this study was to investigate the effect of LiCl on the expression of COX-2 and production of PGE2 in human granulosa-lutein (hGL) cells, as well as the mechanisms underlying this effect. Both immortalized and primary hGL cells were used as research models. Using dual inhibition approaches, our results show that LiCl initiates the hGL cellular action by inhibiting the activity of glycogen synthase kinase-3b [GSK-3b (phosphorylation of GSK-3b)] and activation of extracellular signal-regulated kinase 1/2 (ERK1/2), but not by affecting protein kinase B or cAMP response element binding protein signaling. Additionally, the phosphorylation of GSK-3b, but not ERK1/2, resulted in the stabilization and nuclear localization of b-catenin. Furthermore, knockdown of either b-catenin or GSK-3b reversed the LiCl-induced upregulation of COX-2 expression. These results indicate that LiCl upregulates the expression of COX-2 and the subsequent production of PGE2 through the canonical GSK-3b/b-catenin signaling pathway in hGL cells. (Endocrinology 158: 2813(Endocrinology 158: -2825(Endocrinology 158: , 2017 O vulatory disorder is the most common cause of infertility in humans (1). The ovulatory process is controlled by the luteinizing hormone (LH) surge that induces multiple physiological changes by regulating the expression of various ovulation-related genes, leading to cumulus expansion, meiosis resumption, oocyte maturation, and ovulation (2, 3). Prostaglandin E2 (PGE2) is a critical mediator of oocyte maturation, ovulation, fertilization, and corpus luteum formation (4, 5). The synthesis of PGE2 is tightly controlled by two cyclooxygenase (COX) enzymes, COX-1 [encoded by the prostaglandin H synthase 1 gene (PTGS1)] and COX-2 [encoded by the prostaglandin H synthase 2 gene (PTGS2)] (6). These two COX enzymes catalyze the ratelimiting step of prostaglandin synthesis. In general, COX-1 is constitutively expressed in most mammalian cells and is involved in the maintenance of various homeostatic functions. On the other hand, the expression of COX-2 is relatively low under normal physiological conditions but can be rapidly induced by inflammatory stimuli, hormones, cytokines, and different growth factors (6). In response to the ovulatory LH surge, granulosa cells express the COX-2 enzyme, which then elevates the PGE2 concentration in the follicular fluid (7). Notably, COX-1 Abbreviations: AKT, protein kinase B; COX, cyclooxygenase; CREB, cAMP response element binding protein; CTNNB1, b-catenin; DMEM, Dulbecco's modified Eagle medium; ERK1/2, extracellular signal-regulated kinase 1/2; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSK-3b, glycogen synthase kinase-3b; hGL, human granulosa-lutein; LH, luteinizing hormone; LiCl, lithium chloride; LRP5/6, lipoprotein-related protein 5/6; mRNA, messenger RNA; PGE2, prostaglandin E2; PTGS1, prostaglandin H synthase 1 gene; PTGS2, prostaglandin H synthase 2 gene; RRID, Research Resource Identifier; RT-qPCR, real-time quantitative polymerase chain reaction; SEM, standard error of the mean; siRNA, small interfering RNA; TBST, Tris-buffered saline containing 0.1% Tween 20.
O vulatory disorder is the most common cause of infertility in humans (1) . The ovulatory process is controlled by the luteinizing hormone (LH) surge that induces multiple physiological changes by regulating the expression of various ovulation-related genes, leading to cumulus expansion, meiosis resumption, oocyte maturation, and ovulation (2, 3) . Prostaglandin E2 (PGE2) is a critical mediator of oocyte maturation, ovulation, fertilization, and corpus luteum formation (4, 5) . The synthesis of PGE2 is tightly controlled by two cyclooxygenase (COX) enzymes, COX-1 [encoded by the prostaglandin H synthase 1 gene (PTGS1)] and COX-2 [encoded by the prostaglandin H synthase 2 gene (PTGS2)] (6). These two COX enzymes catalyze the ratelimiting step of prostaglandin synthesis. In general, COX-1 is constitutively expressed in most mammalian cells and is involved in the maintenance of various homeostatic functions. On the other hand, the expression of COX-2 is relatively low under normal physiological conditions but can be rapidly induced by inflammatory stimuli, hormones, cytokines, and different growth factors (6) . In response to the ovulatory LH surge, granulosa cells express the COX-2 enzyme, which then elevates the PGE2 concentration in the follicular fluid (7) . Notably, COX-1 knockout mice exhibit normal ovulation and fertilization (8) , whereas targeted depletion of COX-2 in mice leads to multiple female reproductive defects, including ovulation, fertilization, implantation, and decidualization (9) . Furthermore, the administration of PGE2 can restore ovulation in COX-2 knockout mice (10) . All these studies indicate that COX-2-derived PGE2 plays a critical role during mammalian ovulation.
Lithium chloride (LiCl) is one of the most widely used treatments for bipolar disorder, even though its therapeutic mechanism remains largely unknown (11) . In the last few years, considerable attention has been paid to the important neurotrophic and neuroprotective effects of lithium (12) . Studies in neuroscience have shown that LiCl can be useful in the treatment of acute brain injuries (ischemia disorders) and chronic neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson disease, and Huntington disease) (12) . Recent advances in molecular and cellular biology have demonstrated that LiCl exerts its neuroprotective effect through multiple interacting mechanisms (13) . For instance, LiCl reduces apoptosis by directly inhibiting the activity of glycogen synthase kinase-3b (GSK-3b), which is a type of serine/threonine protein kinase involved in multiple regulatory pathways for diverse cellular activities (14) . GSK-3b is a key mediator of canonical Wnt/b-catenin signaling, which is activated by Wnt proteins. Canonical Wnt/b-catenin signaling starts with the Wnt protein that binds to the membrane Frizzled receptor, as well as to its coreceptor, the low-density lipoprotein-related protein 5/6 (LRP5/6). The binding, in turn, phosphorylates and inactivates the downstream GSK-3b and leads to the stabilization of b-catenin in the cytoplasm, which then translocates into the nucleus and combines with other transcriptional factors to regulate target gene expression (15) . Additionally, lithium ions inhibit GSK-3b by competing with magnesium ions (16) .
Despite extensive studies of LiCl in neuroscience, only a handful of research has attempted to decipher the effects of LiCl on the reproductive system. Undesirable adverse effects on sexual functions in men and women after psychopharmacological treatment with LiCl have been reported (17) . Female patients who have received lithium treatment may experience infertility and ovarian cycle disruption (17) . It has been shown that lithium decreased the serum levels of gonadotropins, prolactin, and testosterone in rats and humans (18, 19) . Additionally, lithium reduced folliculogenesis in rats (20) . Furthermore, an in vitro study showed that lithium delayed oocyte maturation, reduced cumulus expansion, and decreased progesterone production in cattle (21) . However, the effects of lithium on human ovarian functions, especially as they relate to granulosa cell functions, remain to be elucidated. Interestingly, lithium induced the follicular atresia in a GSK-3b/b-catenin-dependent manner in rats and mice (22, 23) . Taken together, all these studies indicate that the expression of COX-2 and the subsequent production of PGE2 could be induced by LiCl through GSK3b/b-catenin signaling in the human ovary. In the current study, we sought to take a closer look at the cellular effects of LiCl on the expression of COX-2 and its derivative PGE2, as well as its underlying molecular mechanism in human granulosa cells.
Materials and Methods

Culture of immortalized human granulosa cells
In this study, we used nontumorigenic immortalized human granulosa cells (SVOG cells) previously obtained from women undergoing in vitro fertilization. Primary human granulosalutein (hGL) cells were transfected with the SV40 large T antigen (24) . These cells have been widely used as a cellular model to study the human follicular functions in several studies (25) (26) (27) (28) (29) (30) . The SVOG cells were cultured in Dulbecco's modified Eagle medium (DMEM)/F12 medium (Sigma, Oakville, ON, Canada) with 10% charcoal/dextran-treated fetal bovine serum (FBS; HyClone Laboratories, Logan, UT), 13 GlutaMAX(Thermo Fisher Scientific/Invitrogen, Grand Island, NY), 100 mg/mL streptomycin sulfate (Thermo Fisher Scientific/Invitrogen), and 100 U/mL penicillin (Thermo Fisher Scientific/Invitrogen). The cells were maintained in a humidified atmosphere with 5% CO 2 and 95% air at 37°C. The culture medium was changed every 2 days, and the cells were maintained in serum-free medium for 24 hours before specific treatments.
Preparation of primary hGL cells
After approval from the University of British Columbia Research Ethics Board and the institutional review board, we obtained primary hGL cells from patients undergoing in vitro fertilization who gave informed consent. These samples were anonymized immediately after collection, and none of the investigators were permitted to access any patient information. Primary hGL cells were purified by density centrifugation from follicular aspirates collected from women undergoing oocyte retrieval as previously described (31, 32) . Purified hGL cells were seeded in DMEM/F12 medium supplemented with 10% charcoal/dextran-treated FBS and cultured at 37°C in a humidified 5% CO 2 /air atmosphere. The culture medium was changed every other day in all experiments. After 2 days of culture, the medium was changed to low serum medium (containing 0.5% charcoal/dextran-treated FBS) and experimental treatments were applied on day 3. (sense) and 5 0 -GACAAGCTTCCCG-TTCTCAG-3 0 (antisense). All the experiments were repeated at least three times, and each sample was assayed in triplicate. A mean value was used to determine messenger RNA (mRNA) levels, using the comparative cycle threshold method with GAPDH as the reference gene (relative quantification comparison).
Antibodies and reagents
Western blot analysis
Cells were lysed in a cell lysis buffer (Cell Signaling) containing a protease inhibitor cocktail (P-2714; Sigma-Aldrich). A total of 30 mg of protein was separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred onto polyvinyl difluoride membranes. After 1 hour of blocking with 5% nonfat dried milk in Tris-buffered saline containing 0.1% Tween 20 (TBST), the membranes were incubated overnight with the indicated primary antibodies (diluted 1:1000 in TBST with 5% nonfat dried milk) at 4°C. Next, the membranes were washed three times with TBST and then incubated for 1 hour with the appropriate peroxidase-conjugated secondary antibodies (diluted at 1:5000 in TBST with 5% nonfat dried milk). Finally, the immunoreactive bands were detected using an enhanced chemiluminescent substrate on an X-ray film. The intensities of the bands were quantified using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD).
Small interfering RNA transfection
To knock down the endogenous GSK-3b and b-catenin, we transfected the cells using 25 nM ON-TARGETplus SMARTpoolrelevant GSK-3b small interfering RNA (siRNA) and catenin b 1 (CTNNB1) siRNA, respectively (Dharmacon, Lafayette, CO). Briefly, the SVOG cells were precultured to 50% confluency in antibiotic-free DMEM/F12 medium containing 10% charcoal/dextran-treated FBS and then transfected with the indicated 25 nM siRNAs using Lipofectamine RNA iMAX (Thermo Fisher Scientific) for 48 hours, as previously described (33) . The siCONTROL Non-Targeting Pool siRNA (Dharmacon) was used as the transfection control. The knockdown efficiency of each target was examined using RT-qPCR or Western blot analysis.
PGE2 enzyme-linked immunosorbent assay
A human PGE2-specific enzyme-linked immunosorbent assay was performed in accordance with the manufacturer's instructions (Cayman Chemical, Ann Arbor, MI). SVOG cells were cultured in a sixwell plate with 2 mL of DMEM/F12 medium. After the treatments had been applied, the culture media and cell lysates were collected, and the concentrations of PGE2 in the culture media were measured using an enzyme-linked immunosorbent assay and then normalized to the protein concentrations in the cell lysate. The normalized PGE2 values are presented as values relative to those of the control group.
Statistical analysis
The results are presented as the mean 6 standard error of the mean (SEM) of at least three independent experiments. Multiple comparisons were analyzed by one-way analysis of variance followed by Tukey multiple comparison tests using PRISM software (GraphPad Software, San Diego, CA). Statistical significance was defined as P , 0.05.
Results
LiCl increased COX-2 expression and PGE2 production in hGL cells
The concentrations of LiCl used in this study were based on many previous studies in which lithium was used as an experimental tool to initiate cellular signaling pathways, with concentrations ranging from 10 to 30 mM. The therapeutic range for lithium in the treatment of mania is 0.5 to 1.5 mM (34) . To investigate the effect of LiCl on the expression of COX enzymes, SVOG cells were treated with different concentrations (i.e., 10, 20, or 30 mM) of LiCl for 6 hours, and the results showed that LiCl significantly increased COX-2 mRNA and protein levels in a concentrationdependent manner [ Fig. 1(a) ]. Furthermore, the time-course studies showed that treatment with LiCl (20 mM) significantly increased COX-2 expression starting at 3 hours (mRNA level) or 6 hours (protein level); these stimulatory effects persisted until 12 hours [ Fig.  1(b) ]. PGE2 is the major product of COX-2 enzymes and plays a vital role in the regulation of ovulation and corpus luteum formation (5). To further investigate whether LiCl-induced COX-2 expression contributes to the increase in PGE2 production, we treated SVOG cells with different concentrations (i.e., 10, 20, or 30 mM) of LiCl for 12 hours and examined the PGE2 concentrations in the culture medium. The results showed that LiCl significantly increased PGE2 levels in the conditioned medium in a concentration-dependent manner [ Fig. 1(c) ]. To further confirm the stimulatory effect of LiCl on COX-2 expression, primary hGL cells obtained from patients undergoing in vitro fertilization were used to examine the effect of LiCl on the expression of COX-2. Consistent with the results from SVOG cells, LiCl treatment (i.e., 20 mM at 6 or 12 hours) significantly increased COX-2 protein levels in human primary granulosa cells [ Fig. 1(d) ].
LiCl did not alter the expression of COX-1 in SVOG cells
To date, two isoforms of the COX enzyme have been identified that mediate the key step of the prostaglandin synthesis (6) . We investigated the effect of LiCl on the expression of COX-1 in hGL cells. As shown in Fig. 2(a) and 2(b) , treatment of SVOG cells with 20 mM LiCl did not alter the COX-1 mRNA and protein levels at any examined time point (i.e., 3, 6, or 12 hours).
LiCl did not provoke protein kinase B/cAMP response element binding protein signaling in SVOG cells
We sought to determine the mechanistic aspects of the molecular pathway by which LiCl stimulates the expression of COX-2. Because LiCl has been shown to hours. The COX-2 protein levels were determined using Western blot analysis. (c) Primary hGL cells were treated with a vehicle control or 20 mM LiCl for 10 or 30 minutes, and the phosphorylated protein levels of GSK-3b were determined using Western blot analysis. The results are expressed as the mean 6 SEM of at least three independent experiments. The bars without a common letter indicate a significant difference exists between those samples (P , 0.05). Ctrl, control; siCtrl, control small interfering RNA; siGSK-3b, GSK-3b small interfering RNA; SVOG, an immortalized human granulosa-lutein cell line.
modulate the stability of b-catenin through the phosphorylation of GSK-3b by mimicking either Wnt or protein kinase B (Akt) signaling pathways in various cell types, we examined the potential effect of LiCl on the downstream Wnt/b-catenin and Akt/cAMP response element binding protein (CREB) effectors (35, 36) . Recombinant human betacellulin and 8-bromoguanosine 3 0 ,5 0 -cyclic monophosphate were used as positive controls to activate and induce the phosphorylation of AKT and CREB, respectively (37, 38) . Compared with the positive controls, the Western blot analysis results showed that LiCl could not induce the phosphorylation of AKT or CREB in SVOG cells, indicating that LiCl cannot activate the AKT/CREB signaling in SVOG cell [ Fig. 3(a) and 3(b) ].
LiCl upregulated COX-2 expression by inhibiting GSK-3b activity in hGL cells
There is emerging evidence from molecular studies indicating that some effects of lithium are mediated through the inhibition of GSK-3b activity (14) . We investigated whether LiCl could induce the phosphorylation of GSK-3b (the inactivated form of GSK3b) in SVOG cells by Western blot analysis. As shown in Fig. 4(a) , the phosphorylated GSK-3b protein levels were significantly increased at 10, 30, and 60 minutes after incubation with 20 mM LiCl. Primary hGL cells were used to confirm the effect of LiCl on the induction of GSK-3b phosphorylation. Consistent with the result from SVOG cells, LiCl significantly increased the phosphorylated GSK-3b protein levels in hGL cells [ Fig. 4(c) ].
To confirm that GSK-3b is required for the LiCl-induced increase in COX-2 expression, we knocked down the endogenous GSK-3b using a siRNA-targeted approach. The result showed that the knockdown of GSK-3b completely reversed the LiCl-induced upregulation of COX-2 expression in SVOG cells [ Fig. 4(b) ]. SVOG cells were treated with a vehicle control or 20 mM LiCl for 3 hours, and the nuclear levels of nonphosphorylated b-catenin protein (using nuclear lamin B as a loading control) were determined using Western blot analysis. (c) Primary hGL cells were treated with a vehicle control or 20 mM LiCl for 3 or 6 hours, and the levels of nonphosphorylated b-catenin protein were determined using Western blot analysis. The results are expressed as the mean 6 SEM of at least three independent experiments. The bars without a common letter indicate a significant difference exists between those samples (P , 0.05). Ctrl, control; SVOG, an immortalized human granulosa-lutein cell line.
LiCl induced nuclear retention of b-catenin in hGL cells
We then examined whether LiCl activates b-catenin in hGL cells. Unlike GSK-3b, the amount of active b-catenin increased from 3 hours after LiCl treatment, whereas there was no effect on the active b-catenin levels at 1 hour [ Fig. 5(a) ]. To examine whether stable b-catenin could translocate into the cell nucleus, we analyzed the total protein of the nucleus using a nuclear extraction reagent. Indeed, the Western blot results showed that treatment with LiCl (20 mM) caused a significant increase in the nuclear retention of b-catenin (using nuclear lamin B as the loading control) in SVOG cells [ Fig. 5(b) ]. Similarly, LiCl significantly increased the nuclear retention of b-catenin in primary hGL cells [ Fig. 5(c) ].
LiCl increased COX-2 expression and PGE2 production through the b-catenin signaling pathway in hGL cells
To determine whether b-catenin signaling is required for the LiCl-induced upregulation of COX-2 expression in human granulosa cells, we next conducted an siRNAmediated knockdown to target the endogenous b-catenin in SVOG cells. As shown in Fig. 6(a) , the knockdown of b-catenin using siRNA resulted in a reduction in the expression of b-catenin protein levels at 24 or 48 hours. Notably, knockdown of b-catenin for 48 hours completely reversed the LiCl-induced increases in COX-2 mRNA [ Fig. 6(b) ] and protein [ Fig. 6(c) ] levels. Most importantly, the LiCl-induced increase in PGE2 production in the conditioned medium was entirely abolished by the Figure 6 . b-Catenin signaling was required for the LiCl-induced increases in COX-2 expression and PGE2 production in SVOG cells. (a) Knockdown efficiency and specificity of siRNA (25 nM CTNNB1) for b-catenin for 24 and 48 hours were determined using Western blot analysis. (b) SVOG cells were transfected with 25 nM of siCtrl or siCTNNB1 for 48 hours, and then they were treated with a vehicle control or 20 mM LiCl for an additional 3 hours. The COX-2 mRNA levels were determined using RT-qPCR. (c) SVOG cells were transfected with 25 nM of siCtrl or siCTNNB1 for 48 hours, and then they were treated with a vehicle control or 20 mM LiCl for an additional 6 hours. The COX-2 protein levels were determined using Western blot analysis. (d) SVOG cells were transfected with 25 nM siCtrl or siCTNNB1 for 48 hours and then treated with a vehicle control or 20 mM LiCl for an additional 12 hours. The PGE2 levels in the conditioned medium were determined using an enzyme immunoassay. The results are expressed as the mean 6 SEM of at least three independent experiments. The bars without a common letter indicate a significant difference exists between those samples (P , 0.05). Ctrl, control; siCTNNB1, CTNNB1 small interfering RNA; siCtrl, control small interfering RNA; SVOG, an immortalized human granulosa-lutein cell line.
knockdown of b-catenin [ Fig. 6(d) ]. Using the same inhibition approach, the results from primary hGL cells showed that the LiCl-induced upregulation of COX-2 protein expression and an increase in PGE2 accumulation were completely abolished by the endogenous b-catenin knockdown [ Fig. 7(a) and 7(b) ]. These data indicated that b-catenin signaling is required for the LiClinduced increases in COX-2 expression and PGE2 production in hGL cells.
Extracellular signal-regulated kinase 1/2 signaling was not involved in the LiCl-induced upregulation of COX-2 expression in SVOG cells Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling has been shown to participate in LiClinduced cellular function in human cancer cells (39) . Here, we examined whether LiCl can activate ERK1/2 signaling in human granulosa cells. Our results showed that the phosphorylated level of ERK1/2 was increased after LiCl treatment at the examined time points [i.e., 10 and 30 minutes; Fig. 8(a) ]. To further confirm whether ERK1/2 signaling is involved in the LiCl-induced upregulation of COX-2, a specific inhibitor (i.e., U0126) of ERK1/2 was used. The results showed that pretreatment with U0126 did not affect the LiCl-induced increases in COX-2 mRNA [ Fig. 8(b) ] or protein [ Fig. 8(c) ] levels, indicating that ERK1/2 signaling is not involved in the LiCl-induced cell activity in SVOG cells.
Discussion
In this study, we demonstrated for the first time, to our knowledge, that treatment with LiCl induces increases in COX-2 expression and PGE2 production in the human granulosa cell line, SVOG. Although LiCl has been therapeutically used to treat bipolar disorder for decades, little is known about the biological function of lithium in human granulosa cells. A previous study using human luteinized granulosa cells showed that LiCl reversed the chemotherapeutic agent-induced decreases in cell viability through the molecular mechanisms that LiCl restores [e.g, b-catenin activation (phosphorylation of b-catenin)], increases the total b-catenin level, and activates GSK3b phosphorylation (40) . In immature female rats, lithium induced follicular atresia by disrupting the balance between proliferation and apoptosis in granulosa cells (22) . An in vitro study in cattle showed that administration of LiCl dose-dependently reduced cumulus expansion and delayed oocyte maturation (21) . In contrast to the studies conducted in mammals, our results showed that lithium induced an increase in the production of COX-2-derived PGE2, which is the main Figure 7 . b-Catenin signaling was required for the LiCl-induced increases in COX-2 expression and PGE2 production in hGL cells. (a) Primary hGL cells were transfected with 25 nM of siCtrl or siCTNNB1 for 48 hours and then treated with a vehicle control or 20 mM LiCl for an additional 6 hours. The COX-2 protein levels were determined using Western blot analysis. (b) Primary hGL cells were transfected with 25 nM siCtrl or siCTNNB1 for 48 hours and then treated with a vehicle control or 20 mM LiCl for an additional 12 hours. The PGE2 levels in the conditioned medium were determined using an enzyme immunoassay. The results are expressed as the mean 6 SEM of at least three independent experiments. The bars without a common letter indicate a significant difference exists between those samples (P , 0.05). Ctrl, control; siCTNNB1, CTNNB1 small interfering RNA; siCtrl, control small interfering RNA.
mediator of cumulus expansion, oocyte maturation, and ovulation. The concentrations of LiCl we used in this study were between 10 and 30 mM, which were similar to those used in animal studies. These concentrations have been shown to be nontoxic to mouse oocytes and embryos (41) . To date, clinical data regarding the human follicular fluid concentrations of lithium after long-term administration are still lacking. Whether higher concentration of lithium might cause adverse effects on human follicular function or PGE2 production remains to be elucidated.
A comprehensive understanding of the underlying molecular mechanism may benefit the development of a therapeutic strategy for ovarian pathology or infertility. Our results demonstrated that the inhibition of GSK-3b activity initiated LiCl-induced COX-2 expression in human granulosa cells. Consistent with this result, the administration of LiCl rapidly inhibited GSK-3b activity by increasing the amount of phosphorylated GSK-3b protein in bovine primary granulosa cells (21) . GSK-3b is an essential protein kinase that regulates various biological activities. Ionic compounds of lithium have been shown to either directly compete with magnesium (16) or indirectly activate AKT signaling to inhibit GSK-3b activity in different cell types (42) . The lithium-induced activation of AKT kinase then activates its downstream nuclear effector CREB by phosphorylation (43) . However, recent studies have shown that the phosphorylation of CREB can be directly mediated by GSK-3b (44) . CREB is a pleiotropic transcription factor, and its phosphorylation at Ser-133 can be induced by various serine/ threonine kinases (45) . Interestingly, our previous study found that CREB signaling was involved in the nitric oxide-induced upregulation of COX-2 in human granulosa cells (38) . These results suggest that the inhibitory effect of LiCl on GSK-3b activity may The mRNA levels of COX-2 were determined using RT-qPCR. (c) SVOG cells were pretreated for 1 hour with DMSO as a vehicle control or ERK1/2 inhibitor U0126 (10 mM) and then treated with 20 mM LiCl for an additional 6 hours. The protein levels of COX-2 were determined using Western blot analysis. The results are expressed as the mean 6 SEM of at least three independent experiments. The bars without a common letter indicate that a significant difference exists between those samples (P , 0.05). Ctrl, control; DMSO, dimethyl sulfoxide; SVOG, an immortalized human granulosa-lutein cell line.
subsequently affect AKT or CREB activity. However, the current study shows that there was no significant increase in the phosphorylation of AKT or CREB after exposing human granulosa cells to LiCl.
LiCl has also been identified as an activator of MEK/ ERK signaling. In acute promyelocytic leukemia cells, LiCl induced the phosphorylation of ERK1/2, which was abolished by the addition of the specific MEK inhibitor U0126 (39) . Chronic lithium treatment increased MEK activity in neurons (46) , and lithium promoted the differentiation of neurons in an ERK-dependent manner (47) . Our study found that LiCl also induced the phosphorylation of ERK1/2 in human granulosa cells, which is consistent with our previous study that showed three epidermal growth factor-like growth factors (amphiregulin, betacellulin, and epiregulin) upregulated COX-2 expression through ERK1/2 signaling (37) . However, although LiCl treatment activated ERK1/2 signaling in human granulosa cells, it did not have any stimulatory effect on the expression of COX-2 in this study. These contradicting results could be because epidermal growth factor-like growth factors not only activate ERK1/2 signaling but also activate or increase other transcription factors essential for COX-2 expression, which does not occur in LiCl-induced ERK1/2 signaling.
In many mammalian cells, GSK-3b is the key mediator of Wnt signaling, and b-catenin is the downstream effector of GSK-3b. Experiments using an siRNA-mediated approach showed that targeted depletion of b-catenin completely abolishes the LiCl-induced increases in COX-2 expression and PGE2 production. Notably, knockdown of endogenous b-catenin not only abolishes the LiCl-induced upregulation of COX-2 expression but also decreases the basal levels of COX-2, indicating that GSK-3b/b-catenin signaling is required for lithium-induced cellular action in human granulosa cells. In the canonical Wnt pathway, the Wnt protein binds to the Frizzled receptor and LRP5/6, and disrupts APC/Axin/GSK-3b (i.e., inactivates the GSK-3b activity), which further induces the accumulation and translocation of the junction-associated protein b-catenin into the nucleus (48).
This active form of b-catenin subsequently forms a complex with Lef/Tcf family members and regulates target gene expression (Fig. 9) . The regulatory effect of b-catenin on the expression of COX-2 is cell-type specific. In human embryonic kidney cells, Wnt/b-catenin indirectly induced the expression of COX-2 by upregulating the PEA3 transcription factor (49) . However, in concert with lymphoid enhancer-binding factor 1 (Lef1), b-catenin directly binds to and activates the promoter of the PTGS2 (COX-2) gene in mouse chondrocytes (50) . Furthermore, the Wnt/b-catenin complex directly increases COX-2 expression through b-catenin regulatory elements at the PTGS2 gene promoter region in gastric cancer cells (51) . Future studies aimed at addressing the transcriptional regulation of b-catenin at the PTGS2 gene in human granulosa cells will be of great interest.
In this study, both primary and immortalized hGL cells were used to investigate the LiCl-induced cellular Figure 9 . Schematic diagram of the proposed molecular mechanisms for the LiCl-induced increases in COX-2 expression and PGE2 production in human granulosa cells. Treatment with LiCl leads to the activation of GSK-3b/b-catenin and ERK1/2 but not of the AKT or CREB signaling pathways. The LiCl-induced activation of ERK1/2 signaling has no effect, whereas the activation of GSK-3b/b-catenin signaling results in the stabilization of cytoplasmic b-catenin, which translocates into the nucleus and combines with LEF/TCF transcription factors to regulate COX-2 expression and PGE2 production. P, phosphorylated; TCF/LEF, T-cell factor/lymphoid enhancer factor. function and signaling. Both cell types were generated from the follicular fluid obtained from the infertile patients. Therefore, SVOG cells retain many physiological characteristics of hGL cells, as shown in our finding that two cell types responded to LiCl in a similar manner. However, we did not study the effect of LiCl interacting with gonadotropins, because these hGL cells have been exposed to the high doses of gonadotropins (i.e., follicle-stimulating hormone and LH/human chorionic gonadotropin). Therefore, the cellular expression levels of gonadotropin receptors (i.e., follicle-stimulating hormone receptors and LH receptors) and, thereby, the cellular response to gonadotropin are relatively low (downregulation of gonadotropin receptors).
In summary, our study demonstrated that LiCl initiates its cellular action by inhibiting the activity of GSK-3b (i.e., phosphorylation of GSK-3b) and the activation of ERK1/2, but not by affecting AKT or CREB signaling. The phosphorylation of GSK-3b (but not ERK1/2) resulted in the stabilization and nuclear localization of b-catenin. The knockdown of either b-catenin or GSK-3b reversed the LiCl-induced upregulation of COX-2 expression, indicating that LiCl increased the expression of COX-2 and the subsequent production of PGE2 through the canonical GSK-3b/b-catenin signaling pathway in human granulosa cells. Our findings shed light on the cellular and molecular mechanisms by which LiCl/GSK3b/b-catenin modulates the ovulatory process in the human ovary.
